Hospital for Special Surgery
535 East 70th Street, 6th Floor
New York, NY 10021
Dr. Doruk Erkan is an Associate Physician-Scientist at the Barbara Volcker Center for Women and Rheumatic Diseases, Associate Attending Rheumatologist and Clinical Researcher at Hospital for Special Surgery, and Associate Professor of Medicine at Weill Cornell Medical College.
In addition to his rheumatology practice, Dr. Erkan has a long-standing research interest in Antiphospholipid Syndrome (an autoimmune clotting disorder) and Systemic Lupus Erythematosus (SLE or “lupus”). After his Internal Medicine residency at Beth Israel Medical Center in New York, he completed his Rheumatology fellowship at Hospital for Special Surgery in New York. Dr. Erkan has a medical doctor (MD) degree from Hacettepe University School of Medicine in Ankara, Turkey and a master of public health (MPH) degree from Johns Hopkins University School of Public Health in Baltimore, Maryland.
Dr. Erkan has received several honors and awards from the American College of Rheumatology and the Arthritis Foundation for his research. He has published over 100 articles including research papers and invited editorials, as well as over 20 book chapters, and he has given over 100 research presentations and 80 invited lectures. He is the co-editor of the Neurology volume of the Handbook of Systemic Autoimmune Disease and the Associate Editor of Hospital for Special Surgery’s Manual of Rheumatology and Outpatient Orthopedic Disorders.
Associate Attending Rheumatologist, Hospital for Special Surgery
Associate Professor of Medicine, Weill Cornell Medical College
Associate Physician-Scientist, Barbara Volcker Center for Women and Rheumatic Disease
Clinical Co-Director, Mary Kirkland Center for Lupus Care
Antiphospholipid syndrome (APS)
Systemic lupus erythematosus (SLE)
APS and SLE Pregnancy
Medical multimedia for physician and patient education
Antiphospholipid Syndrome Research Award, New York Community Trust, 2012
Clinical & Translational Science Center Pilot Award, Cornell Medical College, 2011
Lupus Research Award, New York Community Trust, 2008
Rudd-Gardy Teaching Excellence Award, HSS Division of Rheumatology, 2008
Young Investigator Award, AESKU.KIPP Institute, Germany, 2007
Young Investigator Initiative Award, US Bone and Joint Decade, 2006
Antiphospholipid Syndrome Research Award, New York Community Trust, 2004
Dorothy W. Goldstein Young Scholar Award, Arthritis Foundation, New York Chapter, 2002
Rheumatology Fellow Award, American College of Rheumatology, 2001
Postdoctoral Fellowship Award, Arthritis Foundation, New York Chapter, 2001
American College of Rheumatology, Fellow
New York Rheumatism Association, Executive Committee
APS ACTION, Executive Committee Chair
Blue Cross HMO POS
Blue Cross PPO
Blue Cross Pathway
Blue Cross Pathway Enhanced
If your particular insurance plan is not listed, you may still have coverage subject to the availability of 'out-of-network' benefits. Please do not hesitate to contact our office if you have questions regarding your insurance coverage.
One of the goals of Hospital for Special Surgery (HSS) is to advance the science of orthopedic surgery, rheumatology, and related disciplines for the benefit of patients. Physicians at HSS may collaborate with outside companies for education, research and medical advances. HSS supports this collaboration in order to foster medical breakthroughs; however HSS also believes that these collaborations must be disclosed.
As part of the disclosure process, this website lists physician collaborations with outside companies if payments were received during the prior year, or if the HSS physician currently receives payment. The disclosures are provided by information provided by the physician and other sources and are updated regularly. Further information may be available on individual company websites.
Below are the healthcare industry relationships reported by Dr. Erkan as of April 14, 2015.
By disclosing the collaborations of HSS physicians with industry on this website, HSS and its physicians make this information available to their patients and the public, thus creating a transparent environment for those who are interested in this information. Further, HSS’ Conflicts of Interest Policy does not permit physicians to collect royalties on products developed by him/her that are used on patients at HSS.
Patients should feel free to ask their HSS physicians questions about these relationships.
Medical Doctor (MD), Hacettepe University School of Medicine, Ankara, Turkey
Master of Public Health (MPH), Johns Hopkins University School of Public Health, Baltimore, Maryland
Internal Medicine, Beth Israel Medical Center, New York
American Board of Rheumatology, 2001, 2011
American Board of Internal Medicine, 1999, 2009
Certificate in Clinical Epidemiology and Health Services Research, Weill Cornell Medical College, 2000
- Antiphospholipid Syndrome (APS) and Pregnancy
- Antiphospholipid Syndrome Terminology
- Surgical Procedures in Antiphospholipid Antibody-Positive Patients
- APS ACTION International Clinical Database and Repository
- Catastrophic Antiphospholipid Syndrome
- Prevention of Blood Clots in Antiphospholipid Antibody-Positive Patients
- Lupus and Gender
- Lupus and Cardiovascular Disease
- Lupus and Pregnancy
For more publications, please see the PubMed listing.
Dr. Doruk Erkan has been involved in Antiphospholipid Syndrome (APS) research since 1997. His research interest includes identification of factors that increase the risk of blood clots, potential prevention strategies, and new APS treatments. He is the principal investigator in multiple clinical trials ranging from mechanistic studies to drug trials for difficult-to-treat APS patients. He has been a member of multiple APS-related national/international committees as well as an invited speaker at numerous conferences. He is the Executive Committee Chair of the international APS research network, APS ACTION (Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking). More information about this network can be found at http://www.apsaction.org/.
Dr Erkan was selected to Chair the 15th International Congress on Antiphospholipid Antibodies, which will be held in Istanbul, Turkey in September 2016. Learn more.
Invited Special Lecture Presentations at International Scientific Meetings (Selected, 2011-2013 Only)
May 2011 – Antiphospholipid Syndrome Treatment Beyond Anticoagulation: Are We There Yet? The European League Against Rheumatism (EULAR) Scientific Annual Meeting, London, UK.
August 2011 – Primary Thrombosis Prophylaxis in Antiphospholipid Antibody Positive Patients. ReumaRio 2011 (National Brazil Rheumatology Meeting), Rio de Janeiro, Brazil.
August 2011 – Antiphospholipid Syndrome Management Beyond Anticoagulation. Are We There Yet? ReumaRio 2011 (National Brazil Rheumatology Meeting), Rio de Janeiro, Brazil.
October 2011 – Management of Antiphospholipid Syndrome.12th National Turkish Rheumatology Meeting, Antalya, Turkey.
November 2011 – APS ACTION. APS Study Group, American College of Rheumatology 75th Annual Scientific Meeting, Chicago, IL.
November 2011 – Clinical Symposium: Management of Antiphospholipid Syndrome, From Controversies to Consensus, Primary Thromboprophylaxis. American College of Rheumatology 75th Annual Scientific Meeting, Chicago, IL.
November 2012 – APS Study Group: APS ACTION - Two-year Anniversary, American College of Rheumatology Annual Scientific Meeting, Washington, DC.
November 2012 – Clinical Symposium: Catastrophic Antiphospholipid Syndrome. American College of Rheumatology Annual Scientific Meeting, Washington, DC.
April 2013 – Controversial Aspects of Antiphospholipid Syndrome. 3rd National Portugal Autoimmunity Meeting, Virtual Meet the Expert.
May 2013 – Antiphospholipid Syndrome Management Beyond Anticoagulation. 7th International Advances in Rheumatology Meeting, Santiago, Chile.
May 2013 – Catastrophic Antiphospholipid Syndrome: Where Do We Stand? 7th International Advances in Rheumatology Meeting, Santiago, Chile.
May 2013 – Cardiovascular Disease Prevention Strategies in Lupus and Antiphospholipid Syndrome. 7th International Advances in Rheumatology Meeting, Santiago, Chile.
September 2013 – Antiphospholipid Syndrome Treatment Trends Task Force Report & Recommendations, 14th International Congress on Antiphospholipid Antibodies and 4th Latin American Congress on Autoimmunity (APLA&LACA), Rio de Janeiro, Brazil.
September 2013 – Future of Antiphospholipid Syndrome Treatment. 14th International Congress on Antiphospholipid Antibodies and 4th Latin American Congress on Autoimmunity (APLA&LACA), Rio de Janeiro, Brazil.
October 2013 – Autoantibodies in Diagnosis and Follow-up Rheumatic Diseases Study Group: Improving Antiphospholipid Antibody Testing through International Collaboration (APS ACTION), American College of Rheumatology Annual Scientific Meeting, San Diego, CA.
October 2013 – Antiphospholipid Syndrome. American College of Rheumatology Annual Scientific Meeting Meet the Professor Session Speaker, San Diego, CA.
ONGOING CLINICAL RESEARCH-RELATED WEBSITES:
Hospital for Special Surgery
535 East 70th Street, 6th Floor
New York, NY 10021